Last week, Novo Nordisk, makers of Wegovy and Ozempic, filed a lawsuit against competitor Eli Lilly, makers of Zepbound and Mounjaro, accusing the pharmaceutical giant of deceptively marketing its drugs
Recently, pharmacological inhibition of the NLRP3 inflammasome was reported to alleviate PM2.5- or silica-induced pulmonary inflammation and fibrosis in mice [43, 44]
In the 6-OHDA rat model of PD, GIP showed clear neuroprotective effects [142]
That matters because a working air conditioner that a family is afraid to run is not protection
It contains two long-acting peptide analogues: cagrilintide, a synthetic amylin receptor agonist, and semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist